The Core for this PPG contains four functional interactive units: 1) Tissue Acquisition &Characterization, 2) Databse, Biostatistics &Bioinformatics, 3) MRI Imaging;and 4) Administration. Three of these units (Tissue Acquisition &Characterization;Biostatistics;Administration) were developed to support the activities of the research group during the previous round of support, and are being extended in their current form. We request support for one additional Core Unit (MRI Imaging), to support our proposed research program. The Program Project Group Tissue Acquisition &Characterization (PPG-TAC) Unit is responsible for prospectively identifying brain and spinal cord donors, conducting postmortem MRI imaging in selected MS cases, expeditiously processing brain and spinal cord tissue postmortem, and performing standardized histologic assessment of lesions for the specific purposes of projects 1, 2 and 3 within the program. The Database Management, Biostatistics &Bioinformatics Unit will collaborate with the investigators to optimize study design, ensure statistical power, analyze data requiring statistical expertise, and to design, implement, and manage study databases. The MRI Imaging Unit will coordinate MRI imaging procedures;assure that each protocol results in acceptable image quality;verify quality of primary MRI data;and assist with analysis of the data for Projects 3 and 4. The Administrative Unit will manage the budget, organize investigator and advisory committee meetings and assist with preparation of reports

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS038667-10
Application #
7741647
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
10
Fiscal Year
2009
Total Cost
$142,374
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Trapp, Bruce D; Vignos, Megan; Dudman, Jessica et al. (2018) Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study. Lancet Neurol 17:870-884
Lowe, Mark J; Sakaie, Ken E; Beall, Erik B et al. (2016) Modern Methods for Interrogating the Human Connectome. J Int Neuropsychol Soc 22:105-19
Paz Soldán, M Mateo; Novotna, Martina; Abou Zeid, Nuhad et al. (2015) Relapses and disability accumulation in progressive multiple sclerosis. Neurology 84:81-8
Takeshita, Yukio; Obermeier, Birgit; Cotleur, Anne et al. (2014) An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods 232:165-72
Criste, Gerson; Trapp, Bruce; Dutta, Ranjan (2014) Axonal loss in multiple sclerosis: causes and mechanisms. Handb Clin Neurol 122:101-13
Dutta, Ranjan; Trapp, Bruce D (2014) Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol 27:271-8
Beall, Erik B; Lowe, Mark J (2014) SimPACE: generating simulated motion corrupted BOLD data with synthetic-navigated acquisition for the development and evaluation of SLOMOCO: a new, highly effective slicewise motion correction. Neuroimage 101:21-34
Tutuncu, Melih; Tang, Junger; Zeid, Nuhad Abou et al. (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19:188-98
Rudick, Richard A; Fisher, Elizabeth (2013) Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes. Mult Scler 19:1003-4
Dutta, Ranjan; Chomyk, Anthony M; Chang, Ansi et al. (2013) Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol 73:637-45

Showing the most recent 10 out of 34 publications